UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

1075TiP A phase I/Ib open-label, first-in-human, single agent, dose escalation and expansion study of a HER2-targeted T cell engager (SAR443216) in patients with relapsed/refractory HER2-expressing solid tumors

Annals of oncology, 2023-10, Vol.34, p.S647-S647

2023

Link zum Volltext

Verfügbarkeit prüfen

The relationship between peripheral T cell reactivity to insulin, clinical remissions and cytokine production in type 1 (insulin-dependent) diabetes mellitus

The journal of clinical endocrinology and metabolism, 1999-07, Vol.84 (7), p.2419-2424

1999

Link zum Volltext

Verfügbarkeit prüfen

The Mycoplasma‐derived lipopeptide MALP‐2 is a potent mucosal adjuvant

European journal of immunology, 2002-10, Vol.32 (10), p.2857-2865

2002

Link zum Volltext

Verfügbarkeit prüfen

T cell response pattern to glutamic acid decarboxylase 65 (GAD65) peptides of newly diagnosed type 1 diabetic patients sharing susceptible HLA haplotypes

Clinical and experimental immunology, 1999-07, Vol.117 (1), p.30-37

1999

Link zum Volltext

Verfügbarkeit prüfen

Efficient mucosal delivery of the HIV‐1 Tat protein using the synthetic lipopeptide MALP‐2 as adjuvant

European journal of immunology, 2003-06, Vol.33 (6), p.1548-1556

2003

Link zum Volltext

Verfügbarkeit prüfen

The Mycoplasma-Derived Macrophage-Activating 2-Kilodalton Lipopeptide Triggers Global Immune Activation on Nasal Mucosa-Associated Lymphoid Tissues

Infection and Immunity, 2004-12, Vol.72 (12), p.6978-6986

2004

Link zum Volltext

Verfügbarkeit prüfen

Characterization of a B220+ Lymphoid Cell Subpopulation with Immune Modulatory Functions in Nasal-Associated Lymphoid Tissues

The Journal of immunology (1950), 2005-02, Vol.174 (3), p.1317-1324

2005

Link zum Volltext

Verfügbarkeit prüfen

A Phase 2b Study Evaluating the Efficacy and Safety of Subcutaneously Administered Tregalizumab in Subjects with Active Rheumatoid Arthritis (RA) Despite Treatment with Methotrexate (MTX)

ARTHRITIS & RHEUMATOLOGY, 2015, Vol.67

2015

Link zum Volltext

Verfügbarkeit prüfen

L'isoforme de 65 kDa de l'acide glutamique décarboxylase (GAD65)

Immuno-analyse & biologie spécialisée, 1998, Vol.13 (4), p.219-221

1998

Link zum Volltext

Verfügbarkeit prüfen

Characterization of a Novel Intracellularly Activated Gene from Salmonella enterica Serovar Typhi

Infection and Immunity, 2002-10, Vol.70 (10), p.5404-5411

2002

Link zum Volltext

Verfügbarkeit prüfen

The Relationship between Peripheral T Cell Reactivity to Insulin, Clinical Remissions and Cytokine Production in Type 1 (Insulin-Dependent) Diabetes Mellitus 1

The journal of clinical endocrinology and metabolism, 1999-07, Vol.84 (7), p.2419-2424

1999

Link zum Volltext

Verfügbarkeit prüfen

The Relationship between Peripheral T Cell Reactivity to Insulin, Clinical Remissions and Cytokine Production in Type 1 (Insulin-Dependent) Diabetes Mellitus1

The journal of clinical endocrinology and metabolism, 1999-07, Vol.84 (7), p.2419-2424

1999

Link zum Volltext

Verfügbarkeit prüfen

Peptide specificity of high-titer anti-glutamic acid decarboxylase (GAD)65 autoantibodies

Immunology letters, 1998-07, Vol.62 (3), p.123-130

1998

Link zum Volltext

Verfügbarkeit prüfen

Affinity for the cognate monoclonal antibody of synthetic peptides derived from selection by phage display: Role of sequences flanking the binding motif

European journal of biochemistry, 2000-03, Vol.267 (6), p.1819-1829

2000

Link zum Volltext

Verfügbarkeit prüfen

Répertoire des autoanticorps: application au diabète de type 1

Immuno-analyse & biologie spécialisée, 1999-03, Vol.14 (2), p.89-97

1999

Link zum Volltext

Verfügbarkeit prüfen

Les autoanticorps associés au développement du diabète insulinodépendant

Immuno-analyse & biologie spécialisée, 1995, Vol.10 (5), p.264-269

1995

Link zum Volltext

Verfügbarkeit prüfen

Use Of a Biologic Marker For An Integrated Pharmacodynamic and Clinical Analysis To Inform Further Clinical Development, Including Dose Selection For The Phase 2b Trial - Treat 2b - Of Tregalizumab In Rheumatoid Arthritis

ARTHRITIS AND RHEUMATISM, 2013, Vol.65, p.S596

2013

Link zum Volltext

Verfügbarkeit prüfen

Affinity for the cognate monoclonal antibody of synthetic peptides derived from selection by phage display. Role of sequences flanking thebinding motif

European journal of biochemistry, 2000-03, Vol.267 (6), p.1819-1829

2000

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial

Annals of the rheumatic diseases, 2018-04, Vol.77 (4), p.495

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(17)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Female
(7)
Immunology
(7)
Amino Acid Sequence
(5)
Animals
(5)
Humans
(5)
Mice
(5)
Molecular Sequence Data
(5)
B-Lymphocytes - Immunology
(4)
Biological And Medical Sciences
(4)
Endocrinopathies
(4)
Mice, Inbred Balb C
(4)
Administration, Intranasal
(3)
Adolescent
(3)
Adult
(3)
Diabetes Mellitus, Type 1 - Immunology
(3)
Lipopeptides
(3)
Lymphocyte Activation - Drug Effects
(3)
Male
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

1075TiP A phase I/Ib open-label, first-in-human, single agent, dose escalation and expansion study of a HER2-targeted T cell engager (SAR443216) in patients with relapsed/refractory HER2-expressing solid tumors

The relationship between peripheral T cell reactivity to insulin, clinical remissions and cytokine production in type 1 (insulin-dependent) diabetes mellitus

The Mycoplasma‐derived lipopeptide MALP‐2 is a potent mucosal adjuvant

T cell response pattern to glutamic acid decarboxylase 65 (GAD65) peptides of newly diagnosed type 1 diabetic patients sharing susceptible HLA haplotypes

Efficient mucosal delivery of the HIV‐1 Tat protein using the synthetic lipopeptide MALP‐2 as adjuvant

The Mycoplasma-Derived Macrophage-Activating 2-Kilodalton Lipopeptide Triggers Global Immune Activation on Nasal Mucosa-Associated Lymphoid Tissues

Characterization of a B220+ Lymphoid Cell Subpopulation with Immune Modulatory Functions in Nasal-Associated Lymphoid Tissues

A Phase 2b Study Evaluating the Efficacy and Safety of Subcutaneously Administered Tregalizumab in Subjects with Active Rheumatoid Arthritis (RA) Despite Treatment with Methotrexate (MTX)

L'isoforme de 65 kDa de l'acide glutamique décarboxylase (GAD65)

Characterization of a Novel Intracellularly Activated Gene from Salmonella enterica Serovar Typhi

The Relationship between Peripheral T Cell Reactivity to Insulin, Clinical Remissions and Cytokine Production in Type 1 (Insulin-Dependent) Diabetes Mellitus 1

The Relationship between Peripheral T Cell Reactivity to Insulin, Clinical Remissions and Cytokine Production in Type 1 (Insulin-Dependent) Diabetes Mellitus1

Peptide specificity of high-titer anti-glutamic acid decarboxylase (GAD)65 autoantibodies

Affinity for the cognate monoclonal antibody of synthetic peptides derived from selection by phage display: Role of sequences flanking the binding motif

Répertoire des autoanticorps: application au diabète de type 1

Les autoanticorps associés au développement du diabète insulinodépendant

Use Of a Biologic Marker For An Integrated Pharmacodynamic and Clinical Analysis To Inform Further Clinical Development, Including Dose Selection For The Phase 2b Trial - Treat 2b - Of Tregalizumab In Rheumatoid Arthritis

Affinity for the cognate monoclonal antibody of synthetic peptides derived from selection by phage display. Role of sequences flanking thebinding motif

Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial

Suchergebnisse filtern